Aed drug class

 

^1.Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10, patients with surveillance angiography. Heart ; –9.

^2.Dangas et a.

In-Stent Restenosis in the Drug-Eluting Stent Era. J Am Coll Cardiol ; –

^3.Bhatt D. Treatment of In-Stent Restenosis, Excerpt from Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease.

Aed drug class list

Philadelphia: Elsevier

_4.Ota H. Novel Approaches for Cardiovascular Drug-Eluting Devices Cardiovasc Revasc Med. ; ; Maluenda G. Intracoronary brachytherapy for Recurrent Drug-Eluting Stent Failure CardiovascInterv.

;; Kubo S. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis Euro Intervention. ;; Latib A. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosisJACC Cardiovasc Interv.

;

^5.Pratsos, A. (). Atherectomy and the role of excimer laser in treating CAD. Cardiac I